Skip to main content
Alice Bertaina, MD, Pediatric Hematology & Oncology, Palo Alto, CA

AliceBertainaMD

Pediatric Hematology & Oncology • Palo Alto, CA

ASSOCIATE PROFESSOR OF PEDIATRICS (STEM CELL TRANSPLANTATION) AT THE LUCILE SALTER PACKARD CHILDREN'S HOSPITAL

Join to view full profile

Dr. Bertaina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bertaina's full profile

Already have an account?

  • Office

    725 Welch Rd
    Palo Alto, CA 94304
    Phone+1 650-497-8000

Summary

  • Dr. Alice Bertaina is a pediatric hematologist/oncologist in Palo Alto, CA and is affiliated with Lucile Packard Children's Hospital Stanford. She received her medical degree from University of Pavia Faculty of Medicine and has been in practice 13 years. She is experienced in allogeneic hsct, graft manipulation, physical elimination of alfa/beta t cells and b cells, and allograft of hematopoietic stem cell.

Education & Training

  • University of Pavia Faculty of Medicine
    University of Pavia Faculty of MedicineClass of 2006

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2018 - 2024

Awards, Honors, & Recognition

  • Abstract Travel Award 'Identification of deregulated microRNAs in JMML' International JMML Symposium, 2016
  • Invited to participate in the Annual National Ceremony for Cancer Research, Palazzo del Quirinale President of the Italian Republic, 2015

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • High-Throughput RNA Sequencing Analysis Reveals Distinct Molecular Signature in NRAS and PTPN11 JMML Patients
    Alice Bertaina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Ho...
    Alice Bertaina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Identification of Dual Positive CD19+/CD3+ T Cells in an Apheresis Product Undergoing Chimeric Antigen Receptor (CAR) Transduction
    Alice Bertaina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Other

  • 'alfa/beta T-cell depleted haplo-transplant in children with acute leukemia' 
    Alice Bertaina
    55th ASH Meeting, Engineering Cell Therapies Press Program, New Orleans - 12/2013

Press Mentions

  • Jasper Therapeutics Announces Positive Follow-up Clinical Data from Investigator-Sponsored Study of Briquilimab Conditioning in Fanconi Anemia Patients at the 2023 Transplantation & Cellular Therapy Meetings of the ASTCT and CIBMTR
    Jasper Therapeutics Announces Positive Follow-up Clinical Data from Investigator-Sponsored Study of Briquilimab Conditioning in Fanconi Anemia Patients at the 2023 Transplantation & Cellular Therapy Meetings of the ASTCT and CIBMTRFebruary 17th, 2023
  • Making Transplants Easier for Kids, and Charting a New Approach to Fighting Solid Tumors
    Making Transplants Easier for Kids, and Charting a New Approach to Fighting Solid TumorsNovember 30th, 2022
  • Three Kids Are Thriving After Kidney Transplants with No Immunosuppressants
    Three Kids Are Thriving After Kidney Transplants with No ImmunosuppressantsJune 27th, 2022
  • Join now to see all

Professional Memberships

  • Child Health Research Institute Stanford
    Member
  • Frontiers in Immunology Bone Marrow Transplantation
    Peer Reviewed Journal Reviewer
  • American Society of Hematology - ASH
    Member
  • European Society for Blood and Marrow Transplantation
    Member
  • Comitato per il Controllo delle Infezioni Ospedalerie (CCIO) at the OPBG
    Member

Dr. Alice Bertaina, Dr. Alice Bertaina, MD, Dr. A Bertaina